GrayOS Implementation at CancerCare Manitoba
CancerCare Manitoba (CCMB) has initiated a significant advancement in cancer care by implementing GrayOS, an innovative platform developed by Gray Oncology Solutions. This strategic partnership aims to enhance access to systemic therapy while improving operational efficiency in delivering cancer treatments.
Addressing Challenges in Cancer Care
Much like many cancer treatment facilities across North America, CCMB faces the pressing need to maintain timely access to care in the face of increasing patient volumes and complex treatment pathways. As the incidence of cancer rises and treatments become more personalized, coordinating systemic therapy scheduling has emerged as a multifaceted challenge.
Scheduling systemic therapy is not a straightforward task; it involves managing numerous interrelated factors such as drug preparation, lab test results, resource availability, and tailored treatment protocols. These intricate variables can lead to inefficiencies, resulting in lost treatment capacity. Some centers have reported capacity losses of up to 15%, which in turn can prolong patient wait times and create uneven workloads for healthcare staff.
Enhancing Operations with Advanced Technology
GrayOS equips the teams at CCMB with sophisticated optimization algorithms and scheduling automation tools. This cutting-edge solution enables improved alignment of capacity with patient needs. By forecasting cancellations and automatically adjusting schedules for last-minute changes, GrayOS facilitates seamless coordination between clinical and administrative teams while integrating directly with ARIA, eliminating the need for duplicated data entry.
The introduction of GrayOS is anticipated to streamline the operations of systemic therapy departments, reduce patient wait times significantly, and enhance day-to-day experiences for both patients and staff alike.
AI Innovations for Future Improvements
CCMB’s collaboration with Gray also extends to developing new AI-powered functionalities aimed at further expanding access to care. This initiative aligns with a broader innovation project supported by Scale AI, and details on this development will be revealed in the near future.
Commitment to Quality Care
André Diamant, the CEO of Gray Oncology Solutions, expressed pride in partnering with CCMB. He emphasized the importance of timely, high-quality care, noting, "Our collaboration is vital for enabling care teams to minimize delays, ensuring treatment is delivered when it counts the most."
Ken N. Borce, CCMB’s Vice President of Clinical Operations and Chief Nursing Officer, reiterated the organization’s commitment to innovation, highlighting that all initiatives are designed to improve patient outcomes and enhance the care experience. By integrating GrayOS into systemic therapy workflows, CCMB aims to navigate complex treatment protocols with greater efficiency and flexibility. This technology empowers healthcare professionals to concentrate on what truly matters—providing the highest caliber of care to Manitobans impacted by cancer and blood disorders.
About Gray Oncology Solutions
Gray is a healthcare technology company dedicated to helping care teams manage the operational complexities of delivering patient-centered care. They aim for every patient to receive optimal treatment with maximum efficiency. Founded by a diverse group of medical physicists and professors, Gray combines profound expertise in clinical operations, data science, and systems engineering to transform care coordination. At the heart of their innovation lies GrayOS, the first Care Orchestration Platform (COP) tailored for intricate care environments such as radiotherapy and systemic therapies.
About CancerCare Manitoba
CancerCare Manitoba (CCMB) serves as the provincial authority responsible for planning and setting priorities for cancer and blood disorder services throughout Manitoba. They provide comprehensive care for both children and adults, encompassing prevention, early detection, treatment, supportive, and palliative care.
Partnering with Manitoba Health and regional health authorities, CCMB also engages with donors through the CancerCare Manitoba Foundation to deliver multidisciplinary care while advancing research efforts to enhance outcomes for individuals confronting cancer. CCMB leads and oversees all cancer research in the province via the CancerCare Manitoba Paul Albrechtsen Research Institute.
Frequently Asked Questions
What is GrayOS?
GrayOS is a Care Orchestration Platform designed to optimize care delivery in complex environments like cancer treatment facilities.
How does GrayOS improve cancer care?
It enhances access to systemic therapy and streamlines operations, ultimately reducing patient wait times and improving staff efficiency.
What issues does CancerCare Manitoba face?
CCMB faces rising patient volumes and complex treatment pathways that complicate scheduling and resource management.
What are the future plans for GrayOS?
CCMB and Gray are working on AI-powered features to further improve access to care and operational resilience.
Who leads CancerCare Manitoba?
Ken N. Borce serves as the Vice President of Clinical Operations and Chief Nursing Officer, overseeing innovative care solutions at CCMB.
